Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming
Por um escritor misterioso
Descrição
Structural biology of SARS-CoV-2: open the door for novel
Hypothesis: Alpha-1-antitrypsin is a promising treatment option
Serine Protease Inhibitors Restrict Host Susceptibility to SARS
Study discovers inhibition of SARS-CoV-2 entry priming protein by
Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a
Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS
Peptides and peptidomimetics as therapeutic agents for Covid‐19
Evaluation of cytosine base editing and adenine base editing as a
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and
Frontiers Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role
de
por adulto (o preço varia de acordo com o tamanho do grupo)
